Latest Breaking News On - Vicente pons andreu - Page 1 : vimarsana.com

News of the takeover comes months after Arcline raised a $2.75 billion fund. (Getty/Kritchanut) A private equity group has bought Polypeptide Therapeutic Solutions for its nanoparticle drug delivery technologies. Arcline Investment Management struck the deal in the belief the success of mRNA COVID-19 vaccines has permanently accelerated the rise of nanoparticle delivery. PTS spun out from a Spanish biomedical research center in 2012 and, with the support of investors including Columbus Venture Partners, has established vehicles to transport active substances. The vehicles have multiple applications, including as non-viral vectors to deliver nucleic acids. Increased interest in that use case was a factor in the deal.

United statesJose vicente pons andreuPolypeptide therapeutic solutionsInvestment managementColumbus venture partnersVicente pons andreuNorth americanNorth americaAkron biotechஒன்றுபட்டது மாநிலங்களில்முதலீடு மேலாண்மைகொலம்பஸ் துணிகர கூட்டாளர்கள்வடக்கு அமெரிக்கன்வடக்கு அமெரிக்கா